What are the common impaction sites of ureteric stones?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Impaction Sites of Ureteric Stones

Ureteric stones most commonly lodge at two primary locations: the proximal ureter (just below the ureteropelvic junction) and the ureterovesical junction (UVJ), with the traditional teaching of three narrowing points being largely unsupported by modern evidence. 1, 2, 3

Primary Impaction Sites

Ureterovesical Junction (UVJ)

  • The UVJ is the single most common site of stone impaction, accounting for approximately 53-61% of stones at presentation 1, 3
  • This distal location represents the most frequent site where stones become lodged when patients first present with renal colic 3

Proximal Ureter

  • The second peak occurs in the proximal ureter between the ureteropelvic junction (UPJ) and the iliac vessels, representing 22-34% of impacted stones 1, 3
  • Stones at this location tend to be significantly larger than distal stones, with mean transverse diameters of 8.47 mm versus 6.74 mm distally 4
  • The longitudinal diameter is also greater proximally (11.00 mm versus 7.50 mm) 4

Lower Third Ureter (Above Ischial Spine)

  • A distinct peak exists in the proximal portion of the lower third ureter, above the ischial spine, accounting for approximately 28% of impacted stones requiring surgical intervention 1
  • This location is more proximal than the traditional UVJ site 1

Sites Where Stones Do NOT Commonly Lodge

Iliac Vessel Crossing

  • Contrary to traditional teaching, stones rarely lodge where the ureter crosses the iliac vessels, with only 1-4.7% of stones found at this location 4, 1, 2, 3
  • Multiple studies have failed to demonstrate a peak in stone distribution at this mid-ureteral location 1, 2, 3
  • This challenges the long-held belief that this represents one of three natural narrowing points 2, 3

Mid-Ureter Overall

  • The mid-ureter accounts for only 3-10% of impacted stones 1
  • This region poses unique challenges for treatment due to overlying bone and iliac vessels 5

Clinical Implications by Location

Stone Size Correlation

  • Proximal ureteral stones are consistently larger than distal stones at presentation 4, 6, 3
  • Proximal stones have mean axial diameters of 6.1 mm versus 4.0 mm distally (p<0.001) 3
  • Stone diameter moderately correlates with position (r = -0.47 to -0.55) 3

Treatment Success Rates

  • Ureteroscopy achieves highest stone-free rates for distal stones (94%), compared to mid-ureter (86%) and proximal ureter (81%) 5
  • Medical expulsive therapy (MET) shows higher success for distal stones (94.9%) versus proximal stones (75.6%) 6
  • The greatest benefit of alpha-blocker MET occurs with stones >5 mm in the distal ureter 5

Ureteral Dilatation Patterns

  • The UPJ demonstrates more severe dilatation than the upper ureter (14.39 mm versus 11.45 mm, p<0.001) 4
  • This finding suggests differential responses to obstruction at various ureteral levels 4

Common Pitfall

The traditional teaching of three equal narrowing points (UPJ, iliac vessel crossing, and UVJ) is not supported by contemporary evidence and should be abandoned in favor of the two-peak distribution model 1, 2, 3. This outdated concept may lead to inappropriate expectations about stone location and treatment planning.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.